Sales & Marketing Business strategy and forecasting team: Ally or adversary? It’s 2023 and pharma is moving ahead and leaving behind the COVID-19 aftermath.
Market Access Sponsored The changing face of pharmaceutical launches The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues to evolve, with significant ramifications for new pharmaceutical launches.<
News Novo Nordisk's dropping share price spells the end for CEO Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.